Related Experiment Video
Updated: Jul 11, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer
Nahee Hwang1,2,3, Bo Kyung Yoon1,3, Kyu-Hye Chun1,2,3
1Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Abstract:
Despite advances in cancer therapy, the clinical outcome of patients with gastric cancer remains poor, largely due to tumor heterogeneity. Thus, finding a hidden vulnerability of clinically refractory subtypes of gastric cancer is crucial. Here, we report that chemoresistant gastric cancer cells rely heavily on endocytosis, facilitated by caveolin-1, for survival. caveolin-1 was highly upregulated in the most malignant stem-like/EMT/mesenchymal (SEM)-type gastric cancer cells, allowing caveolin-1-mediated endocytosis and utilization of extracellular proteins via lysosomal degradation. Downregulation of caveolin-1 alone was sufficient to induce cell death in SEM-type gastric cancer cells, emphasizing its importance as a survival mechanism. Consistently, chloroquine, a lysosomal inhibitor, successfully blocked caveolin-1-mediated endocytosis, leading to the marked suppression of tumor growth in chemorefractory gastric cancer cells in vitro, including patient-derived organoids, and in vivo. Together, our findings suggest that caveolin-1-mediated endocytosis is a key metabolic pathway for gastric cancer survival and a potential therapeutic target.
Insights
Chemoresistant gastric cancer cells depend on caveolin-1 for survival via endocytosis. Inhibiting this process, using drugs like chloroquine, suppressed tumor growth, revealing a new therapeutic target.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Gastric cancer poses a significant clinical challenge due to tumor heterogeneity and poor patient outcomes.
- Identifying vulnerabilities in chemoresistant gastric cancer subtypes is critical for developing effective therapies.
Purpose of the Study:
- To investigate the survival mechanisms of chemoresistant gastric cancer cells.
- To identify potential therapeutic targets for refractory gastric cancer.
Main Methods:
- Analysis of caveolin-1 expression in gastric cancer cells.
- Investigating the role of caveolin-1-mediated endocytosis in cell survival.
- Evaluating the efficacy of lysosomal inhibitors (e.g., chloroquine) in vitro and in vivo.
Main Results:
- Caveolin-1 is upregulated in stem-like/EMT/mesenchymal (SEM)-type gastric cancer cells.
- Caveolin-1 facilitates endocytosis and utilization of extracellular proteins for survival.
- Downregulating caveolin-1 induces cell death in SEM-type gastric cancer cells.
- Chloroquine blocks caveolin-1-mediated endocytosis and suppresses tumor growth in vitro and in vivo.
Conclusions:
- Caveolin-1-mediated endocytosis is a crucial survival pathway for chemoresistant gastric cancer.
- Targeting caveolin-1-mediated endocytosis presents a promising therapeutic strategy for gastric cancer.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitogens and the Cell Cycle
Vesicular Tubular Clusters
With the help of motor proteins such...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Intracellular Signaling Affects Focal Adhesions
Some...

